NEW YORK, April 4 - A broad restructuring undertaken at Monsanto today has put a question mark over the future of its many collaborations with genomics and bioinformatics tools and technology companies.

Monsanto said today that its restructuring, which will cost as much as $124 million, would slash about 5 percent of its staff around the world, or between 600 and 700 of its 14,600 employees.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.